← Back to COAG

Hemab Therapeutics Holdings, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 11/08/2026Mar 2026Filed 11/08/2026Jun 2025Filed 11/08/2026Mar 2025Filed 11/08/2026
−$24−$23−$12−$15
−$0.80−$23.98−$12.91−$16.18
30—0.90.9

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.